FTSE 100 pharma giants GSK and Astrazeneca may have escaped the worst of US President Donald Trump’s tariffs, according to a City broker. Pharmaceutical goods appear to be exempt from higher-rate tariffs introduced by President Trump in his Rose Garden ‘Liberation Day’ address on Wednesday, but there is still uncertainty about the impact on the [...]
Full ArticleFTSE 100 pharma giants GSK and Astrazeneca appear to swerve Trump tariffs
City A.M.
0 shares
1 views
You might like
Related news coverage
GSK shares rise as FTSE 100 giant ‘well positioned’ for pharma tariffs
City A.M.
British drugmaker GSK insisted it was “well positioned” to respond to the impact of sector-specific tariffs amid widespread..